D.Fill Hard: Regulatory Status and Market Access for Professionals
For professionals considering D.Fill Hard for their clinics, understanding its regulatory status and market access is fundamental. This overview provides clarity on the certifications and legal standi

For professionals considering D.Fill Hard for their clinics, understanding its regulatory status and market access is fundamental. This overview provides clarity on the certifications and legal standing pertinent to sourcing this hyaluronic acid dermal filler, ensuring informed procurement decisions for your practice.
D.Fill Hard: Product Overview and Manufacturer
D.Fill Hard is a hyaluronic acid (HA) dermal filler manufactured by D.Pharm Co., Ltd., based in South Korea. The product is designed for professional use within aesthetic practices. As with many injectable products, its distribution and use are subject to specific national and international regulations. Understanding these frameworks is crucial for clinics to ensure compliance and patient safety. For those looking to stock a range of HA options, similar products include D.Fill Soft and D.Fill Medium, each formulated for different indications.
Korean Regulatory Landscape: KFDA, GMP, and ISO Certifications
In South Korea, medical devices and aesthetic injectables fall under the oversight of the Ministry of Food and Drug Safety (MFDS), which includes the Korea Food and Drug Administration (KFDA). Products like D.Fill Hard typically require KFDA approval for sale and distribution within the domestic Korean market, indicating compliance with local safety and efficacy standards.
Furthermore, D.Pharm Co., Ltd., as a manufacturer, is expected to adhere to Good Manufacturing Practices (GMP) and hold ISO certifications, such as ISO 13485 for medical devices. These certifications confirm that the manufacturing processes meet internationally recognized quality management system standards, which is a key consideration for global buyers.
International Regulatory Status: CE Mark and FDA Clearance
Access to international markets often requires additional regulatory clearances:
- CE Mark (European Union): For distribution within the European Economic Area (EEA), a product generally requires a CE Mark. This certification indicates conformity with the health, safety, and environmental protection standards for products sold within the EEA. [VERIFY: D.Fill Hard's specific CE Mark status].
- FDA Clearance (United States): Entry into the U.S. market necessitates clearance or approval from the U.S. Food and Drug Administration (FDA). This process is rigorous and specific to each product. [VERIFY: D.Fill Hard's specific FDA clearance status].
Global Market Access for D.Fill Hard
Beyond the EU and US, market access for D.Fill Hard in regions such as the GCC (Gulf Cooperation Council), LATAM (Latin America), and APAC (Asia-Pacific) depends on individual country-specific registrations. Each nation maintains its own health authority and regulatory framework for importing and distributing aesthetic injectables.
Clinic owners and resellers sourcing products for these regions must verify that the product possesses the necessary local registrations. This diligence is paramount to ensure legal compliance and avoid issues related to unauthorized products. For a broader range of HA options and their regional availability, consult a comprehensive Hyaluronic acid dermal filler catalog.
Parallel Imports and Sourcing Diligence
The practice of parallel importing, while sometimes offering competitive pricing, carries significant risks for aesthetic professionals. Products sourced through parallel import channels may lack official traceability, proper storage conditions (cold chain integrity), or direct manufacturer support.
For products like D.Fill Hard, sourcing through authorized distributors helps ensure that clinics receive genuine products with verifiable origins. Always prioritize suppliers who can provide full documentation and assurances regarding product authenticity, as detailed in guides for other injectables like How to Verify Genuine Re N Tox 100unit: A Professional Sourc.
Demanding Certifications from Your Supplier
When sourcing D.Fill Hard, clinics should demand comprehensive documentation from their wholesale supplier. This includes:
- Certificate of Authenticity (COA): Confirming the product's origin and genuine status from the manufacturer.
- Lot Numbers: Traceable identifiers linking specific product batches to manufacturing records.
- Cold Chain Documentation: Proof that temperature-sensitive products were stored and transported under controlled conditions.
- Regulatory Compliance: Evidence of relevant national and international certifications (e.g., KFDA approval, CE Mark) that are valid for the intended market.
Illustrative wholesale pricing for D.Fill Hard begins at $77.4 per unit, with volume tiers offering additional savings: 11+ units for 4% off, 21+ for 5%, 31+ for 6%, and 51+ units for 8% off.
Ensuring the authenticity and traceability of aesthetic injectables like D.Fill Hard is non-negotiable for professional practices. We commit to supplying original products with verifiable lot numbers, supported by manufacturer-issued Certificates of Authenticity. Our logistics uphold strict cold chain protocols to preserve product integrity from origin to your clinic. This commitment to verified sourcing helps establish a foundation of trust and compliance for your operations.
For professional buyers.
What is the primary regulatory status of D.Fill Hard for its origin market?+
Does D.Fill Hard have a CE Mark for the European market?+
Is D.Fill Hard approved by the FDA for the United States market?+
What documentation should I request from a D.Fill Hard supplier?+
What are the risks of sourcing D.Fill Hard through parallel import channels?+
Explore wholesale pricing and verified sourcing options for D.Fill Hard and other hyaluronic acid fillers for your clinic.
Authentic, lot-traceable and cold-chain shipped to verified clinics. Volume pricing unlocks automatically — save up to 8% on orders of 51+ units.


